The US Supreme Court will hear generic drug maker Hikma Pharmaceuticals USA Inc.'s challenge of an appeals court holding that ...

Semaglutide’s U.S. patents keep generics out until around 2031 or 2035, maintaining Novo Nordisk’s exclusivity and high ...

We’ve launched a first-of-its-kind app to help you find out where your generic drugs come from and see the track records of ...

The Supreme Court agreed to review a controversy over so-called skinny labels for medicines, a decision that will be closely ...

Once generic versions of medications are approved, prices drop. Under the current pricing structure set out by the ...

The post Her Daughter Died After Taking a Generic Version of a Lifesaving Drug. This Is What She Wants You to Know. appeared ...

The price of semaglutide drugs could drop by more than 65% when generic versions of Ozempic and Wegovy hit shelves — possibly ...

The Supreme Court of the US (SCOTUS) has agreed to hear a patent dispute between Amarin and Hikma that could have ...

Health Canada is reviewing nine submissions for generic versions of semaglutide, a prescription medication sold under Novo ...

Officials with the FDA have approved the first generic robenacoxib tablets for the control of postoperative pain and ...

Connecticut data from 2022 to 2023 show medications from retail pharmacies accounted for the state's highest health care ...